There are three different options after you finish your initial round of Semaglutide or Tirzepatide: What are contraindications to Semaglutide and Tirzepatide
If you have questions or difficulties, contact the respective technology teams with the contact details provided
Key Players Driving Growth: Novo Nordisk, Sanofi, Eli Lilly and Company., Merck Group, AstraZeneca, Boehringer Ingelheim, Novartis, Johnson & Johnson (Janssen), Pfizer, Roche, Takeda, Bayer, Bristol Myers Squibb, Amgen, SUN PHARMA, Lupin, Cipla, Teva Pharmaceuticals, MannKind Corporation, Biocon
Clinical trial data shows reduced albumin-to-creatinine ratios and no increased risk of adverse renal events, acute kidney injury, or kidney stones